Master of Biomedical Innovation and Development
MBID (Biomedical Innovation & Development) Master’s program at Georgia Tech, Atlanta, GA, provides the specialized training, exposure and skill sets required for the rigors of product development of high quality medical devices. The program goal is to create potential future leaders of the medical device industry who will promote innovation, entrepreneurship, and commercialization of novel medical devices for global use. Since the inception of the program in 2013, MBID has grown to be a signature Professional Master’s program at Georgia Tech and gained international recognition across both academia and industry. Each cohort averages between 25-35 students.
The program brings together students from diverse engineering and science backgrounds (including healthcare professionals) to work in multi-disciplinary teams develop new products for the medical industry. The curricula combines traditional in-class education with a project-based learning environment. Students are assembled into product development teams that will define an unmet clinical need then use a traditional Phase Gate development process to develop a medical device. Students employ standard operating procedures, work instructions, and template documents in the creation of a medical product that addresses their unmet clinical need. By the end of the program, each team will have a prototype, verification data, medical device files, a business plan, a financial model, a provisional patent application, and a draft grant application. The MBID faculty is composed of leaders from the medical device industry, practicing clinicians, and GT professors. This teaching team uses real-world methods and tools in the curriculum to simulate current practices in medical product development. The program operates in cohorts and only accepts applicants who can start in the Fall semester.
The program graduates have been successfully placed in various roles within the medical device industry functions (such as R&D, Quality, Manufacturing, Marketing, Regulatory, Clinical, Business Development, Project Management, Venture Capital, Sales, Product Management, etc.). Graduates have been employed by start-ups as well as device industry leaders such as Becton Dickinson, Medtronic, J&J, Abbott, Intuitive Surgical, Cook Medical, Boston Scientific, and Stryker in USA and abroad. A three minute video clipping giving overview of program objectives: http://mbid.bme.gatech.edu/content/video-overview
Further details on the program can be found on the program web site at: http://mbid.bme.gatech.edu/
For further information, please contact the MBID Program Director: Prof. Michael Fisher, michael.fisher@bme.gatech.edu, Tel: 774-766-2793.
| Code | Title | Credit Hours |
|---|---|---|
| BMED 6501 | Fundamentals of Biomedical Innovation and Development Processes | 3 |
| BMED 6502 | BioID Clinical Literacy and Experience | 3 |
| BMED 6503 | Medical Markets and Clinical Specialties | 3 |
| BMED 6504 | Financial Planning for Development Projects | 3 |
| BMED 6505 | Product Planning and Project Management | 3 |
| BMED 6506 | Professional Communications for Biomedical Innovation and Development | 3 |
| BMED 6507 | Medical Device Regulatory Requirements | 3 |
| BMED 6508 | BioID Team Masters Project I | 3 |
| BMED 6509 | BioID Masters Project II | 6 |
| Graduate Electives 1 | 6 | |
| Total Credit Hours | 36 | |
| 1 | Graduate electives must be taken during Spring semester due to timing of other program requirements. Electives may be any 6000-level or higher courses. |